Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.62 USD | +1.69% | +8.44% | +14.56% |
Financials (USD)
Sales 2024 * | 19.11M | Sales 2025 * | 97.66M | Capitalization | 2.99B |
---|---|---|---|---|---|
Net income 2024 * | -165M | Net income 2025 * | -126M | EV / Sales 2024 * | 124 x |
Net cash position 2024 * | 618M | Net cash position 2025 * | 514M | EV / Sales 2025 * | 25.3 x |
P/E ratio 2024 * |
-18
x | P/E ratio 2025 * |
-23.5
x | Employees | 124 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on IDEAYA Biosciences, Inc.
1 day | +1.39% | ||
1 week | +7.66% | ||
Current month | -7.77% | ||
1 month | -4.82% | ||
3 months | -8.48% | ||
6 months | +57.10% | ||
Current year | +13.74% |
Managers | Title | Age | Since |
---|---|---|---|
Yujiro Hata
FOU | Founder | 49 | 15-05-31 |
Andres Briseno
DFI | Director of Finance/CFO | 38 | 16-07-31 |
Michael White
CTO | Chief Tech/Sci/R&D Officer | - | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Terry Rosen
BRD | Director/Board Member | 64 | 16-05-05 |
Wendy Yarno
BRD | Director/Board Member | 68 | 19-12-16 |
Catherine Mackey
BRD | Director/Board Member | 68 | 22-04-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.24% | 2 M€ | -.--% | ||
0.09% | 7 M€ | -.--% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 40.78 | +2.10% | 285 497 |
24-04-26 | 39.94 | +3.42% | 619,378 |
24-04-25 | 38.62 | -3.09% | 734,655 |
24-04-24 | 39.85 | +2.13% | 1,369,718 |
24-04-23 | 39.02 | +3.80% | 486,221 |
Delayed Quote Nasdaq, April 29, 2024 at 11:01 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.74% | 2.99B | |
+2.17% | 42.75B | |
+47.81% | 41.61B | |
+12.30% | 41.34B | |
-12.36% | 26.59B | |
+8.53% | 25.49B | |
-23.57% | 18.12B | |
+30.80% | 12.24B | |
-1.85% | 11.76B | |
+8.54% | 11B |
- Stock Market
- Equities
- IDYA Stock